Global market valuation was derived through revenue mapping and transaction volume analysis. The methodology included:
Identification of 50+ key e-commerce platforms and digital health companies across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa
Product mapping across pharmaceuticals (prescription & OTC), medical devices, personal care products, nutritional supplements, and health & wellness categories
Analysis of reported and modeled annual revenues specific to healthcare e-commerce portfolios
Coverage of platforms representing 72-78% of global market share in 2024
Extrapolation using bottom-up (transaction volume × average order value by country/region) and top-down (platform revenue validation) approaches to derive segment-specific valuations
Integration of payment method analytics (credit/debit cards, digital wallets, net banking, cash on delivery) and service feature adoption rates (telehealth integration, home delivery, subscription models, online consultations)
Consumer demographic profiling across adults (18-35), middle-aged (36-55), and seniors (56+) segments to assess cohort-specific spending patterns and platform preferences